Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xencor Inc | 1,035,407 | reported | 06 Dec 2013 | tx 2+1,035,407−3,209,763 |
| ADVANCIS PHARMACEUTICAL CORP | 20,000 | reported | 23 Jun 2009 | tx 6+1,655,000 |
| GENVEC INC | 15,000 | reported | 13 Jun 2007 | tx 2+15,000−6,854,462 |
| CYPHERPUNK TECHNOLOGIES INC. | 2,137 | reported | 30 Jul 2018 | tx 1+2,137 |
| PROTEOSTASIS THERAPEUTICS, INC. | 0 | reported | 17 Feb 2016 | tx 6+2,164,095−14,079,750 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jul 2018 | OTHER | CYPHERPUNK TECHNOLOGIES INC. | 2,137 | 0.00 USD | deriv |
| 17 Feb 2016 | CONVERSION | PROTEOSTASIS THERAPEUTICS, INC. | 1,774,295 | — | |
| 17 Feb 2016 | PURCHASE | PROTEOSTASIS THERAPEUTICS, INC. | 375,000 | 8.00 USD | first after silence |
| 17 Feb 2016 | CONVERSION | PROTEOSTASIS THERAPEUTICS, INC. | 11,600,000 | 0.00 USD | deriv |
| 17 Feb 2016 | OTHER | PROTEOSTASIS THERAPEUTICS, INC. | 14,800 | 0.00 USD | deriv |
| 17 Feb 2016 | OTHER | PROTEOSTASIS THERAPEUTICS, INC. | 160,000 | 0.00 USD | deriv |
| 17 Feb 2016 | CONVERSION | PROTEOSTASIS THERAPEUTICS, INC. | 2,319,750 | 0.00 USD | deriv |
| 06 Dec 2013 | CONVERSION | Xencor Inc | 1,035,407 | 0.00 USD | |
| 06 Dec 2013 | CONVERSION | Xencor Inc | 3,209,763 | 0.00 USD | deriv |
| 23 Jun 2009 | GRANT_AWARD | ADVANCIS PHARMACEUTICAL CORP | 20,000 | 0.00 USD | deriv |
| 04 Jun 2008 | GRANT_AWARD | ADVANCIS PHARMACEUTICAL CORP | 20,000 | 0.00 USD | deriv |
| 13 Jun 2007 | GRANT_AWARD | GENVEC INC | 15,000 | 0.00 USD | deriv |
| 21 May 2007 | GRANT_AWARD | ADVANCIS PHARMACEUTICAL CORP | 20,000 | 0.00 USD | deriv |
| 12 Apr 2007 | PURCHASE | ADVANCIS PHARMACEUTICAL CORP | 900,000 | 2.36 USD | |
| 12 Apr 2007 | PURCHASE | ADVANCIS PHARMACEUTICAL CORP | 675,000 | 2.36 USD | deriv |
| 23 Jun 2006 | SALE | GENVEC INC | 6,854,462 | 1.25 USD | |
| 24 May 2006 | GRANT_AWARD | ADVANCIS PHARMACEUTICAL CORP | 20,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 17 Feb 2016.